• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Funding - Articles and news items

texas-flag-cover

Bellicum recommended for $16.9 million Texan cancer research award

Industry news / 22 November 2016 / Niamh Louise Marriott, Digital Content Producer

The Institute of Texas award would fund a 3 year global clinical program of clinical trials for adult and paediatric patients acute myeloid leukaemia…

eprf

F is for Funding

Blog / 21 November 2016 / Niamh Louise Marriott, Digital Content Producer

F is for Funding – the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest grants and funds…

nasal-spray-vaccine

Mucosis’ needle-free nasal spray vaccine for RSV trial starts

Industry news / 8 November 2016 / Niamh Louise Marriott, Digital Content Producer

Mucosis has begun a first-in-human study of its intranasal Respiratory Syncytial Virus (RSV) vaccine candidate, SynGEM, at Imperial College London…

hyperglycaemia

Post-meal hyperglycaemia has negative impact on diabetic quality of life

Industry news / 4 November 2016 / Niamh Louise Marriott, Digital Content Producer

New data from a study related to post-meal or postprandial glucose control, show that poor PPG control has a negative impact on diabetics quality of life…

money-for-medicine

Verastem licenses Duvelisib from Infinity Pharmaceuticals for $28 million

Industry news / 3 November 2016 / Niamh Louise Marriott, Digital Content Producer

Verastem licensed exclusive worldwide rights to develop and commercialise Infinity’s oncology product candidate duvelisib…

phase-iii-mrsa

MicuRx’S Phase III MRSA antibiotic trial to support Chinese NDA filing

Industry news / 20 October 2016 / Niamh Louise Marriott, Digital Content Producer

The recent $55M Series C financing will allow MicuRx to complete this Phase 3 study, and at a vital time with antibiotic resistance at an all time high…

big pharma

How Big Pharma’s money is affecting our health and our wallets

Blog, Z Homepage promo / 17 October 2016 / Rebecca Hill, TheLawFirm.com

Read Injury Lawyer Rebecca Hill’s review on how Big Pharma’s money is affecting our health and our wallets and the suggestions for change…

head and neck cancer

‘Game-changing’ immunotherapy doubles head and neck cancer survival

Industry news, Z Homepage promo / 10 October 2016 / Niamh Louise Marriott, Digital Content Producer

An immunotherapy drug has been hailed as a ‘game changer’ after being found to greatly improve survival for patients with relapsed head and neck cancer…

drugs-food-cancer

NICE recommends first drug for the Cancer Drugs Fund

Industry news / 4 October 2016 / Niamh Louise Marriott, Digital Content Producer

Osimertinib is the first new cancer drug to be introduced into the NHS under a Cancer Drugs Fund managed access agreement…

inflammatory

MedImmune out-licenses inflammatory diseases medicine to Allergan

Industry news / 3 October 2016 / Niamh Louise Marriott, Digital Content Producer

MEDI2070 is an IL-23 monoclonal antibody currently in a Phase IIb trial for Crohn’s disease (a chronic inflammatory disease of the intestines) and is…

children

NICE recommends new rare inherited bone disorder drug for children

Industry news / 28 September 2016 / Niamh Louise Marriott, Digital Content Producer

The drug is the first treatment to target hypophosphatasia, a condition affecting the development of bone, and could allow children to lead a normal life…

blood-pressure-hypertension

Major global study reveals new hypertension and blood pressure genes

Industry news / 13 September 2016 / Niamh Louise Marriott, Digital Content Producer

The discoveries include DNA changes in three rare genes that have much larger effects on blood pressure in the population than previously seen, providing new insights into the physiology of hypertension and suggesting new targets for treatment…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +